https://www.selleckchem.com/products/bmn-673.html
metabolic (p0.001) complications were highest for patients with phenotype I, followed by phenotype II. Patients with phenotype I had a far greater odds of hepatic (p0.001) and hematological (p=0.02) complications than the other two phenotypes. Phenotypes I and II were associated with 7.30-fold (HR 7.30, 95% CI (3.11-17.17), p0.001) and 2.57-fold (HR 2.57, 95% CI (1.10-6.0, p=0.03) increases in the hazard of death, respectively, when compared to phenotype III. In this retrospective analysis of patients with COVID-19, three
Like
Comment
Share
